ImmunoGen (IMGN) Q4 Earnings and Revenues Beat Estimates

ImmunoGen (IMGN) came out with quarterly earnings of $0.03 per share, beating the Zacks Consensus Estimate of a loss of $0.05 per share. This compares to loss of $0.28 per share a year ago. These figures are adjusted for non-recurring items.